Corteva, Inc. (LON:0A1W)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 39.01B +5.6% |
| Revenue (ttm) | 13.42B +3.7% |
| Net Income | 760.48M -28.0% |
| EPS | 1.13 -26.4% |
| Shares Out | n/a |
| PE Ratio | 51.30 |
| Forward PE | 21.09 |
| Dividend | 0.54 (0.81%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 18 |
| Open | 78.58 |
| Previous Close | n/a |
| Day's Range | 78.58 - 78.58 |
| 52-Week Range | 51.35 - 78.58 |
| Beta | 0.56 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profit... [Read more]
Financial Performance
In 2025, Corteva's revenue was $17.40 billion, an increase of 2.92% compared to the previous year's $16.91 billion. Earnings were $1.09 billion, an increase of 20.62%.
Financial numbers in USD Financial StatementsNews
Corteva Earnings Call Transcript: Q2 2026
Strong first-half 2026 results included 4% sales growth and 10% EBITDA growth, driven by robust execution in both seed and crop protection. Full-year guidance was raised, the planned separation into Corteva and Vylor remains on track, and margin expansion continues despite ongoing pricing pressure in select markets.
Corteva Slides: Q2 2026
Corteva has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 31, 2026.
Corteva Earnings release: Q2 2026
Corteva released its Q2 2026 earnings on July 31, 2026, summarizing the period's financial results.
Corteva Quarterly report: Q2 2026
Corteva has published its Q2 2026 quarterly earnings report on July 31, 2026.
Corteva remains on-track to complete planned separation
Chuck Magro, Chief Executive Officer: “Our strong first half was fueled by demand for next-gen Seed technologies, differentiated Crop Protection products, and focused execution. This level of performa...
Corteva reports Q2 adjusted EPS $2.30, consensus $2.23
Reports Q2 revenue $6.38B, consensus $6.6B.
Corteva raises FY26 operating EPS view to $3.60-$3.80 from $3.45-$3.70
FY26 consensus $3.76. Raises FY26 operating EBITDA view to $4.1B-$4.3B from $4B-$4.2B. “Strong demand remains the defining feature of the agricultural landscape, supporting overall fundamentals across...
Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation
Seed 1H results reflect continued value capture on latest in-demand germplasm and trait technologies, including licensing growth Crop Protection 1H demand for new products and focus on operational exc...
Corteva Declares Quarterly Dividend
INDIANAPOLIS, July 24, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors has authorized a common stock dividend of $0.18 cents per share, payable September 15, 202...
Corteva price target raised to $103 from $97 at RBC Capital
RBC Capital analyst Arun Viswanathan raised the firm’s price target on Corteva (CTVA) to $103 from $97 and keeps an Outperform rating on the shares as part of a broader…
Corteva price target raised to $96 from $90 at BofA
BofA raised the firm’s price target on Corteva (CTVA) to $96 from $90 and keeps a Buy rating on the shares. The firm is adjusting estimates to reflect a volatile…
Corteva price target raised to $97 from $96 at Mizuho
Mizuho raised the firm’s price target on Corteva (CTVA) to $97 from $96 and keeps an Outperform rating on the shares. The firm adjusted targets in the chemicals group as…
NY AG sues 3M, Corteva, DuPont over toxic pollution from consumer products
New York Attorney General Letitia James sued some of the nation’s largest chemical and agricultural companies – 3M Company (MMM), EIDP, The Chemours Company (CC), Corteva, Inc. (CTVA), and DuPont…
Corteva and Arevo Partner on Soy Crop Nutrition
The partnership will help farmers in Europe improve nutrient use efficiency The partnership will help farmers in Europe improve nutrient use efficiency
Corteva price target raised to $96 from $94 at Mizuho
Mizuho raised the firm’s price target on Corteva (CTVA) to $96 from $94 and keeps an Outperform rating on the shares following a review of the company’s SEC filing for…
Corteva Announces Board of Directors for Future Crop Protection Company
Greg Page to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today its intended board of directors as a standalone publicly-tr...
Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor
Karen Grimes to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today the board of directors for Vylor Inc., the future public...
Corteva Transcript: Wolfe Research 3rd Annual Materials of the Future Conference 2026
EU approval of gene editing marks a major regulatory shift, enabling new crop technologies and global market expansion. Proprietary innovation, AI-driven breeding, and hybrid wheat are set to drive growth, while the spin-off structure enhances strategic focus and financial performance.
FMC, Corteva announce co-exclusive rimisoxafen supply and license pact
FMC (FMC) and Corteva (CTVA) announced a co-exclusive strategic supply and license agreement that will expand access to FMC’s rimisoxafen technology across North and South America corn and soybean mar...
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology
Strategic supply and license agreement will accelerate access for North and South American corn and soybean growers PHILADELPHIA and INDIANAPOLIS, June 16, 2026 /PRNewswire/ -- FMC Corporation (NYSE: ...
Corteva to cease production activities at site in Asturias, Spain
In a regulatory filing, the company said, “Corteva (CTVA) has been executing a multi-year footprint optimization and productivity initiative designed to enhance efficiency and reduce structural costs ...
Corteva price target raised to $91 from $84 at Barclays
Barclays analyst Benjamin Theurer raised the firm’s price target on Corteva (CTVA) to $91 from $84 and keeps an Overweight rating on the shares. The firm updated its valuation assumptions…
Corteva to Participate in Wolfe's Materials of the Future Conference
INDIANAPOLIS, June 10, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Chief Financial Officer, David Johnson, and Chief Technology and Digital Officer, Sam Eathington, will speak at Wo...
Corteva price target lowered to $86 from $90 at UBS
UBS analyst Joshua Spector lowered the firm’s price target on Corteva (CTVA) to $86 from $90 and keeps a Neutral rating on the shares.
Corteva price target raised to $95 from $84 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews raised the firm’s price target on Corteva (CTVA) to $95 from $84 and keeps an Overweight rating on the shares. The market is valuing “New…